ArticleScientific reports2026
Self- and observer-rated functioning and psychiatric readmission: findings from multicenter longitudinal data.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
We examined self- and observer-rated functioning across four groups defined by psychiatric readmission status. Data were derived from Early Discharge and Prognostic Community Outcomes for Psychiatric Inpatients in Japan, including 483 patients discharged from acute psychiatric wards. Self-rated functioning (Sheehan Disability Scale, SDS) and observer-rated functioning (Personal and Social Performance Scale, PSP) were assessed at index admission, discharge, and 6- and 12-month follow-ups after discharge. Participants were divided into four groups: readmission at both follow-ups, readmission at 6-month follow-up, readmission at 12-month follow-up, and no readmission. Between-group and within-group changes were examined using generalized linear mixed models. For PSP, the no-readmission group showed significantly better scores than the readmission groups at 6-month (adjusted p = 0.002) and 12-month (adjusted p < 0.001) follow-ups. Excluding the group with readmission at both follow-ups, the remaining three groups demonstrated improvements across all time points through 12 months after discharge. For SDS, scores improved over time only in the no-readmission group (adjusted p < 0.001). These findings indicate that changes in functioning differed according to readmission status. Improvements were more pronounced in observer-rated functioning, whereas self-rated functioning showed limited change. This discrepancy may reflect differences between self- and observer-rated assessments.Clinical trial registration: This study was registered in the UMIN Clinical Trials Registry (UMIN000034220).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.